Vincent Milano

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
7 years
Director since
2023

7 years of board service in total across 2 boards, counting each seat separately. Longest: BioCryst Pharmaceuticals Inc., 3 years.

3 years · Since 2023
3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 31, 2026 BioCryst Pharmaceuticals Inc. Grant or award +1,159 $9.70 $11,242
Jun 11, 2026 BioCryst Pharmaceuticals Inc. Grant or award +15,294 — —
Jun 5, 2026 Aclaris Therapeutics Inc. Option exercise +11,580 — —
May 29, 2026 BioCryst Pharmaceuticals Inc. Grant or award +1,122 $8.91 $9,997
Feb 27, 2026 BioCryst Pharmaceuticals Inc. Grant or award +848 $8.75 $7,420
Nov 28, 2025 BioCryst Pharmaceuticals Inc. Grant or award +783 $7.18 $5,622
Aug 29, 2025 BioCryst Pharmaceuticals Inc. Grant or award +676 $8.31 $5,618
Jun 12, 2025 BioCryst Pharmaceuticals Inc. Grant or award +12,500 — —
Jun 6, 2025 Aclaris Therapeutics Inc. Option exercise +4,793 — —
May 30, 2025 BioCryst Pharmaceuticals Inc. Grant or award +523 $10.75 $5,622
Feb 28, 2025 BioCryst Pharmaceuticals Inc. Grant or award +653 $8.61 $5,622
Nov 29, 2024 BioCryst Pharmaceuticals Inc. Grant or award +750 $7.50 $5,625
Aug 30, 2024 BioCryst Pharmaceuticals Inc. Grant or award +647 $8.69 $5,622
Jun 12, 2024 BioCryst Pharmaceuticals Inc. Grant or award +6,820 — —
Jun 1, 2024 Aclaris Therapeutics Inc. Option exercise +4,660 — —

Questions about Vincent Milano

What boards is Vincent Milano on?

Vincent Milano sits on the boards of Aclaris Therapeutics Inc. and BioCryst Pharmaceuticals Inc.

How long has Vincent Milano served on boards?

Our records show at least 7 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.